Fredun Pharmaceuticals Limited (FPL) has acquired Furlicks, a pet-wellness brand offering convenient oral-strip solutions, from pharma major USV and its subsidiary Wellbeing Nutrition. The acquisition marks FPL’s strategic entry into India’s growing pet-wellness market and provides an opportunity to combine Furlicks’ product innovation and consumer understanding with FPL’s capabilities in manufacturing, product development, quality systems, research and development, supply chain and distribution.
The acquisition comes as pet parenting in India continues to evolve from a predominantly need-based approach towards a greater focus on preventive health, nutrition and specialised wellness products. Furlicks addresses this emerging demand through its oral-strip format, providing pet parents with a convenient alternative to conventional supplement formats. Its existing portfolio covers several key categories, including skin and coat, gut health, joint care, calming, oral care and multivitamins, creating a platform for further product development and category expansion.
Fredun Medhora, Managing Director and CFO, Fredun Pharmaceuticals Limited, said the acquisition represents a new chapter in the company’s expansion into pet wellness. He said Furlicks is more than an addition to FPL’s portfolio and offers the potential to develop a broader pet-wellness business by combining its innovation and consumer-focused approach with FPL’s manufacturing capabilities, scale and execution strength. The company plans to scale the brand while retaining its focus on innovation, simplicity and the evolving needs of pet parents.
FPL’s immediate priority will be to expand the existing Furlicks portfolio, with 12 new stock-keeping units (SKUs) planned in the first phase, followed by 32 additional SKUs in the second phase. Over the longer term, the company aims to develop Furlicks beyond its differentiated oral-strip proposition into a comprehensive everyday pet-wellness platform addressing a broader range of preventive health and nutritional needs.
The acquisition also provides FPL with an opportunity to leverage its established infrastructure and operational capabilities to expand the reach of Furlicks across India. By combining manufacturing, research and development, quality management, supply chain and distribution capabilities with Furlicks’ consumer-oriented product proposition, the company intends to strengthen accessibility to specialised pet-care solutions.
Fredun Pharmaceuticals Limited is a healthcare company with more than four decades of experience across pharmaceuticals, healthcare, consumer wellness and specialised healthcare categories. Through its businesses and subsidiaries, the company has developed capabilities spanning product development, manufacturing, distribution and consumer-focused healthcare solutions.
Furlicks is a pet-wellness brand focused on simplifying everyday pet care through innovative oral-strip formats. Its portfolio includes solutions for skin and coat, gut health, joint care, calming, oral care and multivitamins, with products designed around the convenience requirements of modern pet parents. The acquisition is expected to provide the brand with additional resources and capabilities to expand its product portfolio and market presence.